Cumberland Pharma Files

Cumberland Pharmaceuticals Inc., a Nashville, Tenn.-based specialty drug company that acquires and commercializes niche products, has filed for a $115 million IPO. It plans to trade on the Nasdaq under ticker symbol CPIX, with UBS serving as lead underwriters. Shareholders include Scout Healthcare Fund. www.cumberlandpharma.com